• Je něco špatně v tomto záznamu ?

Challenges in prospective observational studies evaluating pressure ulcer costs: how to price the items correctly

A. Pokorná, L. Krupová, K. Benešová, J. Mužík, J. Jarkovský, P. Búrilová, D. Dolanová, S. Saibertová, M. Klugar, M. Krupa

. 2023 ; 32 (9) : 579-586. [pub] 2023Sep02

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu pozorovací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016292

OBJECTIVE: Pressure ulcers (PUs) are a significant healthcare problem with a negative impact on patients' quality of life and incurring substantial healthcare expenses. Our study aimed to analyse the costs of treating PUs in hospitalised patients in the Czech Republic, in the context of current treatment procedures and price levels, and to pilot-test the detailed methodology developed. METHOD: A prospective, observational, non-interventional study was conducted at the Clinic of Anesthesiology, Resuscitation and Intensive Medicine, the Internal Medicine Department and the Surgical Department of the University Hospital Ostrava. The study included all hospitalised patients with a PU from March-May 2021. Data were collected using the hospital information system. A bottom-up, person-based approach to cost analysis was used, based on a comprehensive cost structure using accurate patient-specific consumption records. RESULTS: The length of hospitalisations ranged from 1-31 (mean: 12.7) days. The average cost of PU treatment per hospitalisation was calculated at €1579. The average daily cost of PU treatment was €179, including antibiotic therapy (ATB) and €112 without ATB. Most of the costs were associated with ATB (38.6%) and caregivers' time (35.9%). Based on the results, a predictive model was developed to estimate the cost of treating a hospitalised patient with a PU, which could be used in future research to assess the costs of treating these patients. CONCLUSION: We have faced many challenges in the methodology of preparation of cost analysis (e.g., how to count amorphous topical agents and sprays, how to properly identify PUs, how to price the positioning aids and mattresses, and how to relate the ATB treatment to the PU). This analysis provides important input for developing a comprehensive and more accurate methodology for monitoring PU costs in hospitalised patients, applicable in clinical practice for inpatient healthcare providers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016292
003      
CZ-PrNML
005      
20231026110044.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.12968/jowc.2023.32.9.579 $2 doi
035    __
$a (PubMed)37682788
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pokorná, Andrea $u Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Challenges in prospective observational studies evaluating pressure ulcer costs: how to price the items correctly / $c A. Pokorná, L. Krupová, K. Benešová, J. Mužík, J. Jarkovský, P. Búrilová, D. Dolanová, S. Saibertová, M. Klugar, M. Krupa
520    9_
$a OBJECTIVE: Pressure ulcers (PUs) are a significant healthcare problem with a negative impact on patients' quality of life and incurring substantial healthcare expenses. Our study aimed to analyse the costs of treating PUs in hospitalised patients in the Czech Republic, in the context of current treatment procedures and price levels, and to pilot-test the detailed methodology developed. METHOD: A prospective, observational, non-interventional study was conducted at the Clinic of Anesthesiology, Resuscitation and Intensive Medicine, the Internal Medicine Department and the Surgical Department of the University Hospital Ostrava. The study included all hospitalised patients with a PU from March-May 2021. Data were collected using the hospital information system. A bottom-up, person-based approach to cost analysis was used, based on a comprehensive cost structure using accurate patient-specific consumption records. RESULTS: The length of hospitalisations ranged from 1-31 (mean: 12.7) days. The average cost of PU treatment per hospitalisation was calculated at €1579. The average daily cost of PU treatment was €179, including antibiotic therapy (ATB) and €112 without ATB. Most of the costs were associated with ATB (38.6%) and caregivers' time (35.9%). Based on the results, a predictive model was developed to estimate the cost of treating a hospitalised patient with a PU, which could be used in future research to assess the costs of treating these patients. CONCLUSION: We have faced many challenges in the methodology of preparation of cost analysis (e.g., how to count amorphous topical agents and sprays, how to properly identify PUs, how to price the positioning aids and mattresses, and how to relate the ATB treatment to the PU). This analysis provides important input for developing a comprehensive and more accurate methodology for monitoring PU costs in hospitalised patients, applicable in clinical practice for inpatient healthcare providers.
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
650    12
$a dekubity $x terapie $7 D003668
650    _2
$a kvalita života $7 D011788
650    _2
$a ambulantní zařízení $7 D000554
650    _2
$a hnisání $7 D013492
655    _2
$a pozorovací studie $7 D064888
655    _2
$a časopisecké články $7 D016428
700    1_
$a Krupová, Lenka $u Department of Dermatology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Benešová, Klára $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Mužík, Jan $u Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Jarkovský, Jirí $u Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Búrilová, Petra $u Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Public Health, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Dolanová, Dana $u Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Saibertová, Simona $u Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Klugar, Miloslav $u Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Krupa, Miroslav $u Faculty of Business Administration, Prague University of Economics and Business, Praha, Czech Republic
773    0_
$w MED00169280 $t Journal of wound care $x 0969-0700 $g Roč. 32, č. 9 (2023), s. 579-586
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37682788 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110038 $b ABA008
999    __
$a ok $b bmc $g 2000045 $s 1202654
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 32 $c 9 $d 579-586 $e 2023Sep02 $i 0969-0700 $m Journal of wound care $n J. wound care $x MED00169280
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace